港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

高瓴概念

509.662

+21.0214.30%

涨家数：44

跌家数：8

平家数：3

市盈率：- -

高：511.922

开：493.898

低：493.493

收：488.641

数据加载中...

俄罗斯财政部讨论允许“超高资格投资者”参与加密货币交易

第一三共/阿斯利康(AZN.US)重磅抗体偶联药物(ADC)Enhertu在3期临床试验中获得积极结果

*ST金科参股金科服务股票拍卖流拍二次拍卖起拍价8.81亿元

广州越秀产业投资有限公司增持新天绿色能源(00956)233万股每股作价3.721港元

中证港股通医药卫生综合指数上涨2.5%，前十大权重包含信达生物等

3月5日睿远稳进配置两年持有混合A净值增长0.54%，近6个月累计上涨9.89%

俄罗斯财政部可能允许合格投资者进行加密货币交易

华东医药(000963.SZ)：三类医疗器械光学射频治疗仪V30注册申请获得受理

京东美团对垒外卖业务之际抖音下场更新补贴政策

石药(01093.HK)：新药JMT108获批于中国开展临床试验

阿斯达克财经

石药集团(01093)开发的I类新药双功能融合蛋白药物JMT108获中国临床试验批准

沛嘉医疗(09996.HK)Trilogy经导管心脏瓣膜系统于台湾完成首两宗植入

阿斯达克财经

沛嘉医疗-B(09996)：TrilogyTM经导管心脏瓣膜系统于中国台湾的首两例植入成功完成

有赞(08083)根据股份奖励计划转让15.76亿股库存股份

华为与海螺水泥联合发布建材行业人工智能技术应用成果

Bitget推出质押借贷VIP权益计划，最高可享20%利率折扣

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1583/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":509.66202,"timestamp":1741162099081,"preClose":488.6409,"halted":0,"volume":639103754,"delay":0,"changeRate":0.04302,"change":21.021118,"pbRate":2.400119,"amount":14348469744.5,"amplitude":0.037714,"prevYearClose":446.93042,"fiveDayClose":514.521,"twentyDayClose":452.099,"turnoverRate":0.004746,"marketCap":2618218524288,"floatMarketCap":2189326024832,"peRate":33.321806},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":511.9219,"amplitude":0.037714,"preClose":488.6409,"low":493.4934,"pbRate":"2.400119","latestPrice":509.66202,"volume":639103754,"delay":0,"open":493.89767,"prevYearClose":446.93042,"prevWeekClose":492.906,"prevMonthClose":492.906,"prevQuarterClose":446.93,"fiveDayClose":514.521,"twentyDayClose":452.099,"sixtyDayClose":478.022,"secType":"PLATE","market":"HK","turnoverRate":0.004746,"peRate":33.321806,"marketCap":2618218524288,"floatMarketCap":2189326024832,"timestamp":1741162099081,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":44,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517912637","title":"俄罗斯财政部讨论允许“超高资格投资者”参与加密货币交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912637","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912637?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 21:48","pubTimestamp":1741182480,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/284271","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4600","BK1583","BK4595","159940","BK4084","BK1542","BK1258","EPR","09983","BK4170","BK1229","BK4234","EBON"],"gpt_icon":0},{"id":"2517111989","title":"第一三共/阿斯利康(AZN.US)重磅抗体偶联药物(ADC)Enhertu在3期临床试验中获得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2517111989","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517111989?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 21:15","pubTimestamp":1741180517,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，阿斯利康和第一三共公司日前宣布，双方联合开发的重磅抗体偶联药物Enhertu，在3期临床试验DESTINY-Gastric04中获得积极结果。新闻稿表示，Enhertu是首个在随机3期临床试验中，作为二线疗法显著改善HER2阳性胃癌患者总生存期的HER2靶向疗法。新闻稿指出，转移性HER2阳性胃癌一线治疗出现疾病进展后，历史上在随机临床试验中，尚未有HER2靶向药物在二线治疗中展示出生存获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320765992.SGD","LU2456880835.USD","BK1576","BK4231","LU0109394709.USD","LU1829250122.USD","LU2417539215.USD","BK4588","ADC","BK4080","LU2462157665.USD","BK1583","BK1141","AZN","BK4568","BK4007","LU2236285917.USD","03347","LU0889565916.HKD","BK4585"],"gpt_icon":0},{"id":"2517911280","title":"*ST金科参股金科服务股票拍卖流拍 二次拍卖起拍价8.81亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911280","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517911280?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 21:06","pubTimestamp":1741179986,"startTime":"0","endTime":"0","summary":"3月5日，*ST金科发布公告，关于其参股公司金科服务的股票拍卖进展情况。根据公告，因司法重整工作的需要，公司持有并质押给BroadGongga Investment Pte. Ltd.的1.08亿股金科服务股票于2025年2月28日至3月1日的首次拍卖流拍。公司计划于2025年3月12日至3月13日进行第二次拍卖，拍卖起拍价为8.81亿元，折合每股8.17元。如果拍卖成功，公司持有金科服务的股权比例将会降低。2024年前三季度，*ST金科实现收入215.67亿元，归母净利润-53.32亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305210714963ac4d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305210714963ac4d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1258","BK1542","09666","BK1229","BK1583"],"gpt_icon":0},{"id":"2517291634","title":"广州越秀产业投资有限公司增持新天绿色能源(00956)233万股 每股作价3.721港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517291634","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517291634?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 20:24","pubTimestamp":1741177478,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，2月28日，广州越秀产业投资有限公司增持新天绿色能源(00956)233万股，每股作价3.721港元，总金额为866.993万港元。增持后最新持股数目约为1.48亿股，最新持股比例为8.03%。本交易涉及其他关联方：广州越秀集团股份有限公司(Guangzhou Yue Xiu Holdings Limited)和广州越秀资本控股集团股份有限公司(Guangzhou Yuexiu Capital Holdings Group Company Limited)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1594","BK1503","BK1166","00956","BK1558","BK1583"],"gpt_icon":0},{"id":"2517153709","title":"中证港股通医药卫生综合指数上涨2.5%，前十大权重包含信达生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2517153709","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517153709?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 20:09","pubTimestamp":1741176540,"startTime":"0","endTime":"0","summary":"数据统计显示，中证港股通医药卫生综合指数近一个月上涨14.07%，近三个月上涨10.66%，年至今上涨15.80%。据了解，中证港股通医药卫生综合指数从港股通范围内选取50只流动性较好、市值较大的医疗卫生行业上市公司证券作为指数样本，以反映港股通范围内医药卫生上市公司证券的整体表现。从中证港股通医药卫生综合指数持仓样本的行业来看，医药卫生占比100.00%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/05200948546293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","LU2328871848.SGD","HSTECH","BK1589","000008.SH","LU1969619763.USD","01801","YANG","BK1583","LU2488822045.USD","HSCEI"],"gpt_icon":1},{"id":"2517991331","title":"3月5日睿远稳进配置两年持有混合A净值增长0.54%，近6个月累计上涨9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991331","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991331?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 19:55","pubTimestamp":1741175705,"startTime":"0","endTime":"0","summary":"金融界2025年3月5日消息，睿远稳进配置两年持有混合A 最新净值1.0804元，增长0.54%。该基金近1个月收益率3.26%，同类排名27|674；近6个月收益率9.89%，同类排名83|663；今年来收益率2.92%，同类排名44|671。公开资料显示，睿远稳进配置两年持有混合A基金成立于2021年12月6日，截至2024年12月31日，睿远稳进配置两年持有混合A规模39.01亿元，基金经理为饶刚、侯振新。2015年4月起加入上海东方证券资产管理有限公司。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/05195548545948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1229","BK1258","BK1583","BK1542","09983"],"gpt_icon":0},{"id":"2517644997","title":"俄罗斯财政部可能允许合格投资者进行加密货币交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2517644997","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517644997?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 18:56","pubTimestamp":1741172195,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 俄罗斯财政部和俄罗斯央行正在讨论在实验性法律框架（ЭПР）内启动俄罗斯国内的加密货币交易。财政部金融政策司司长阿列克谢·雅科夫列夫向记者透露了这一消息。\n交易参与者将属于“超级合格”投资者类别，目前该类别的认定标准仍在制定中。\n“我们正在研究如何在实验性法律框架内启动国内的加密货币交易市场。但这里涉及的是‘超级合格’投资者，这是一个尚未定义的类别，我们正在确定其标准。”雅科夫列夫在资产管理市场领导者论坛的会场上表示。\n雅科夫列夫补充说，财政部希望这一方案能在近期得到落实。“有三个关键因素：实验性法律框架、超级合格投资者以及所有风险的控制。如果这三个因素都能实现，那么我们可能会提出一个方案，并将其提交政府审议。目前，这仍是财政部、央行和市场参与者之间的讨论阶段。”\n2024 年 8 月初，俄罗斯总统弗拉基米尔·普京签署了一项法律，该法律允许从 2024 年 9 月 1 日起，在实验性法律框架内进行跨境支付和加密货币交易。央行被指定为该领域的授权监管机构。(TASS-RU)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/421912?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BITO","IBIT","SNX.USD.HKCC","BK4585","BK1258","DOT.USD.HKCC","09983","BK4594","LTC.USD.HKCC","HODL","UNI.USD.CC","BK4601","TON.USD.HKCC","DOT.USD.CC","BK1229","BK1542","BK1583","GBTC","BTCO","APT.USD.HKCC","159940","SNX.USD.CC","BTCW","VBTC.AU","ATOM.USD.HKCC","FBTC","MKR.USD.CC","BK4588","LDO.USD.HKCC","TON.USD.CC","LINK.USD.HKCC","USDT.USD.CC","AVAX.USD.CC","AVAX.USD.HKCC","COMP.USD.CC","COMP.USD.HKCC","DYDX.USD.HKCC","EZBC","APT.USD.CC","DEFI","BRRR","UNI.USD.HKCC"],"gpt_icon":0},{"id":"2517499730","title":"华东医药(000963.SZ)：三类医疗器械光学射频治疗仪V30注册申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499730","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499730?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 18:52","pubTimestamp":1741171927,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药 发布公告，2025年3月5日，公司全资子公司Viora Ltd.收到国家药品监督管理局签发的《受理通知书》，其申报的三类医疗器械光学射频治疗仪V30注册申请获得受理。V系列产品兼容性强，可适配未来Viora开发的新技术。V30已获得美国FDA、欧盟 CE注册认证。本次V30顺利完成注册受理，是其在中国注册进程中的又一个重大里程碑，公司后续将继续积极推进这款产品在中国的注册工作，推动其早日在国内上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0188","BK0187","BK0209","LU2328871848.SGD","BK0183","09996","BK1222","BK0196","000963","BK0175","BK1574","BK1583","LU1969619763.USD","09997","BK1100","BK0132"],"gpt_icon":0},{"id":"2517979739","title":"京东美团对垒外卖业务之际 抖音下场更新补贴政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2517979739","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517979739?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 18:38","pubTimestamp":1741171109,"startTime":"0","endTime":"0","summary":"3月5日，抖音生活服务宣布面向中小商家推出系列扶持计划，具体包括资源补贴、佣金减免、免费培训等政策。本地生活领域的上一场小规模“战役”刚刚发生在2月，京东外卖正式上线，宣布2025年5月1日前入驻的商家将享受全年免佣金政策。外界将此举定性为对美团“领地”的侵蚀。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503053337392032.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053337392032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1152091754.HKD","LU1188198961.HKD","BK1142","BK1583","LU0873338254.USD","LU1152091168.USD","LU0228659784.USD","HMTD.SI","IE00BF5LJ272.USD","LU1044876610.USD","LU0348805143.USD","IE00B543WZ88.USD","LU0067412154.USD","LU0611395673.USD","LU0683595622.HKD","LU2097828805.USD","IE00BGV7N243.SGD","IE0032431581.USD","BK4585","LU0143863198.USD","SG9999002562.SGD","LU1868837722.USD","BK4220","MPNGY","LU0708995583.HKD","LU0469268626.HKD","LU0345775950.USD","LU0605514214.HKD","LU1328615791.USD","LU0588545904.SGD","BK4531","LU0823426480.USD","89618","LU0029875118.USD","LU0307460666.USD","LU0384037296.USD","LU0315178854.USD","LU1868838027.USD","BK4551","LU0048597586.USD","LU0106252389.USD","LU0456846285.SGD","LU0488056044.USD","LU0672654166.SGD","LU0737861699.HKD","LU0823040885.USD","03690","LU2242644610.SGD"],"gpt_icon":1},{"id":"2517996020","title":"石药(01093.HK)：新药JMT108获批于中国开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2517996020","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517996020?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 17:25","pubTimestamp":1741166700,"startTime":"0","endTime":"0","summary":"石药集团(01093.HK) 公布，由集团开发的一类新药双功能融合蛋白药物JMT108，已获国家药品监督管理局批准，可在中国开展临床试验。该产品是一种重组全人源抗PD-1且融合IL-15的双功能融合蛋白，本次获批的临床适应症为晚期恶性肿瘤。集团表示，临床前研究显示该产品的适应症广泛，在多种恶性肿瘤模型中具有显著的抗肿瘤作用及良好的安全性，具有较高的临床开发价值。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-05 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422393/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1008478684.HKD","03347","BK1141","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1226288253.USD","LU1152091168.USD","LU1226287792.SGD","LU1960683339.HKD","LU1226287875.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","BK1583","LU1152091754.HKD","LU1993786604.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","BK1515","LU1807302812.USD","LU0140636845.USD","LU1226287529.USD","LU0067412154.USD","LU0072913022.USD","LU1226288170.HKD","LU1951186391.HKD","IE0008369823.USD","LU0880133367.SGD","01093","BK1521","IE00B031HY20.USD","LU0326950275.SGD","BK1191","IE0008368742.USD","BK1576"],"gpt_icon":0},{"id":"2517299674","title":"石药集团(01093)开发的I类新药双功能融合蛋白药物JMT108获中国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517299674","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517299674?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 17:22","pubTimestamp":1741166538,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)公布，该集团开发的I类新药双功能融合蛋白药物JMT108已获中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。该产品是一种重组全人源抗PD-1且融合IL-15的双功能融合蛋白，通过靶向PD-1阳性肿瘤浸润免疫细胞，解除PD-1和PD-L1相互作用导致的免疫抑制，并通过PD-1抗体结合依赖性地激活IL-15下游信号通路，进一步促进相关免疫细胞的增殖和活化，从而达到增强的抗肿瘤疗效。本次获批的临床适应症为晚期恶性肿瘤。临床前研究显示，该产品的适应症广泛，在多种恶性肿瘤模型中具有显著的抗肿瘤作用及良好的安全性，具有较高的临床开发价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","BK1576","LU0072913022.USD","LU1993786604.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1226288253.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU0140636845.USD","BK1521","BK1515","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","01093","LU0501845795.SGD","IE0008368742.USD","LU1960683339.HKD","LU0067412154.USD","BK1583","BK1191","LU1951186391.HKD","LU1226287792.SGD","03347","LU1226287529.USD","LU1226287875.USD","IE0008369823.USD","LU1152091168.USD","LU0326950275.SGD","LU0880133367.SGD","BK1141","LU1807302812.USD","LU1152091754.HKD","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2517980009","title":"沛嘉医疗(09996.HK)Trilogy经导管心脏瓣膜系统于台湾完成首两宗植入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517980009","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517980009?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:56","pubTimestamp":1741164960,"startTime":"0","endTime":"0","summary":"沛嘉医疗(09996.HK) 宣布，用于治疗重度主动脉瓣反流的Trilogy经导管心脏瓣膜系统，已于台湾完成首两例植入。(gc/j)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-05 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200911173949451_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200911173949451_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422380/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09996","BK1100","BK1583","BK1574","159891"],"gpt_icon":0},{"id":"2517725998","title":"沛嘉医疗-B(09996)：TrilogyTM经导管心脏瓣膜系统于中国台湾的首两例植入成功完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2517725998","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517725998?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:55","pubTimestamp":1741164936,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沛嘉医疗-B(09996)公布，用于治疗重度主动脉瓣反流的 TrilogyTM经导管心脏瓣膜(THV)系统于中国台湾的首两例植入成功完成。TrilogyTM THV系统为拥有独占许可并获得CE标志认证的经导管主动脉瓣置换产品，适用于心脏团队(包括心脏外科医生)判定为外科主动脉瓣置换手术风险高或较高的症状性重度主动脉瓣反流或症状性重度主动脉瓣狭窄患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1574","159891","BK1100","BK1583"],"gpt_icon":0},{"id":"2517591998","title":"有赞(08083)根据股份奖励计划转让15.76亿股库存股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2517591998","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517591998?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:42","pubTimestamp":1741164157,"startTime":"0","endTime":"0","summary":"智通财经APP讯，有赞(08083)发布公告，于2025年3月5日，该公司根据股份奖励计划转让15.76亿股库存股份予受托人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1516","08083","BK1590","BK1109","BK1583","BK1518"],"gpt_icon":0},{"id":"2517599862","title":"华为与海螺水泥联合发布建材行业人工智能技术应用成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2517599862","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517599862?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:34","pubTimestamp":1741163670,"startTime":"0","endTime":"0","summary":"人民财讯3月5日电，3月4日，MWC25巴塞罗那期间，华为联合海螺水泥发布建材行业人工智能技术应用成果。双方围绕建设建材行业大模型，助力水泥生产实现全自动调优等方面的创新实践经验。依托华为云盘古预测大模型，双方实现了建材行业大模型的典型场景突破，一是熟料强度预测，二是烧成全局寻优。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053337273897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1505","BK1583","BK1507","00914","BK1563","BK1135","LU1328615791.USD","BK1594"],"gpt_icon":0},{"id":"2517991228","title":"Bitget推出质押借贷VIP权益计划，最高可享20%利率折扣","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991228","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991228?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 16:18","pubTimestamp":1741162680,"startTime":"0","endTime":"0","summary":"3 月 5 日，Bitget 推出质押借贷 VIP 权益计划，根据用户 VIP 等级可享受不同阶梯的利率折扣，折扣区间为 2%-20%，助力用户优化资金成本和资产配置。Bitget VIP 用户不仅可尊享杠杆借贷利率折扣，还可优先申购专属高息理财宝产品，享受个性化资产配置方案、一对一大客户经理服务、","market":"us","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/150.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/150.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/787653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["UBmain","09983","ZBmain","ZNmain","ZFmain","BK1258","BK1583","ZTmain","VIP","BK1229","BK1542","TNmain"],"gpt_icon":0}],"pageSize":16,"totalPage":58,"pageCount":1,"totalSize":919}]}}